An Intervention Study to Reduce Drug-related Problems and Readmissions Among Old People With Dementia
NCT ID: NCT01504672
Last Updated: 2021-11-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
460 participants
INTERVENTIONAL
2012-01-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Four hundred and sixty patients will be recruited and randomized to control (usual care) and intervention group (enhanced service in which a pharmacist is part of the health care team).
Six months after the last patient of the 460 has been discharged the study will be closed. Data about the number of readmissions and visits to the emergency room will be collected during the six-month follow-up and also, the costs associated with each visit or admission. Time until institutionalization will be compared between intervention group and control group.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Medication review
Medication review
In the intervention, the pharmacist will evaluate:
* Is there an indication for the drug?
* Has the drug desired effect?
* Is the dose correct and dosing scheme correct?
* Side effects, contraindications, inappropriate drugs
* Interactions
* Treatment time
* Cost effectiveness
* Adherence to recommendation list
* Problems with handling the drugs (for example crushing of the tablets)
* Untreated indication
* Double medications
* Administration of drugs
Usual care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medication review
In the intervention, the pharmacist will evaluate:
* Is there an indication for the drug?
* Has the drug desired effect?
* Is the dose correct and dosing scheme correct?
* Side effects, contraindications, inappropriate drugs
* Interactions
* Treatment time
* Cost effectiveness
* Adherence to recommendation list
* Problems with handling the drugs (for example crushing of the tablets)
* Untreated indication
* Double medications
* Administration of drugs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients ≥ 65 years
Exclusion Criteria
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Umeå University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hugo Lovheim
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hugo Lövheim, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Umeå University, Umeå, Sweden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
County hospital of Skellefteå
Skellefteå, , Sweden
Umeå University Hospital
Umeå, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gustafsson M, Sjolander M, Pfister B, Jonsson J, Schneede J, Lovheim H. Pharmacist participation in hospital ward teams and hospital readmission rates among people with dementia: a randomized controlled trial. Eur J Clin Pharmacol. 2017 Jul;73(7):827-835. doi: 10.1007/s00228-017-2249-8. Epub 2017 Apr 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UmU-2011-148-31M
Identifier Type: -
Identifier Source: org_study_id